Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia: a systematic review

Research output: Contribution to journalReviewResearchpeer-review

Standard

Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia : a systematic review. / Marks, Kevin P; Madsen Sjö, Nina; Wilson, Philip.

In: Developmental Medicine and Child Neurology, Vol. 61, No. 4, 2019, p. 419-430.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Marks, KP, Madsen Sjö, N & Wilson, P 2019, 'Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia: a systematic review', Developmental Medicine and Child Neurology, vol. 61, no. 4, pp. 419-430. https://doi.org/10.1111/dmcn.14044

APA

Marks, K. P., Madsen Sjö, N., & Wilson, P. (2019). Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia: a systematic review. Developmental Medicine and Child Neurology, 61(4), 419-430. https://doi.org/10.1111/dmcn.14044

Vancouver

Marks KP, Madsen Sjö N, Wilson P. Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia: a systematic review. Developmental Medicine and Child Neurology. 2019;61(4):419-430. https://doi.org/10.1111/dmcn.14044

Author

Marks, Kevin P ; Madsen Sjö, Nina ; Wilson, Philip. / Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia : a systematic review. In: Developmental Medicine and Child Neurology. 2019 ; Vol. 61, No. 4. pp. 419-430.

Bibtex

@article{1f053ae16dd24875a9205e170ca5b5c8,
title = "Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia: a systematic review",
abstract = "AIM: The aim of this systematic review was to investigate screening practices with the Ages and Stages Questionnaires (ASQ) and the Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) in the USA and Scandinavia and to identify practical lessons and research opportunities.METHOD: The review was performed for ASQ- and ASQ:SE-related studies in children from birth to 5 years. From nine databases and 1689 references (published from 1988-2018), 127 articles were included and categorized using Covidence online software. The Critical Appraisal Skills Programme Checklists were used before data synthesis.RESULTS: US studies primarily use the ASQ/ASQ:SE to detect delays in general and at-risk populations in medical settings, which increases early detection, clinician-referral, and intervention rates. Scandinavian studies commonly use the ASQ/ASQ:SE to monitor developmental-behavioural differences in intervention/exposure-based cohorts. Pre-visit screening yields completion/return rates of 83{\%} to more than 90{\%} and fosters same-day interpretation. When referrals are indicated, systemwide care coordination or colocation with a developmental-behavioural specialist is beneficial.INTERPRETATION: Practical implementation lessons are reviewed. Research opportunities include investigating and measuring the ASQ/ASQ:SE's 'overall' sections. Danish, Norwegian, and Swedish translations are available but up-to-date norming and validation studies are needed throughout Scandinavia. Randomized controlled trials are needed to investigate outcomes in screened versus unscreened cohorts.WHAT THIS PAPER ADDS: General and at-risk populations broadly benefited from periodic Ages and Stages Questionnaires (ASQ) and/or Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) screening. Pre-visit ASQ and/or ASQ:SE screenining implementation systems work best. The ASQ and ASQ:SE 'overall' sections are not quantifiable and under-researched.",
author = "Marks, {Kevin P} and {Madsen Sj{\"o}}, Nina and Philip Wilson",
note = "{\circledC} 2018 Mac Keith Press.",
year = "2019",
doi = "10.1111/dmcn.14044",
language = "English",
volume = "61",
pages = "419--430",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Comparative use of the Ages and Stages Questionnaires in the USA and Scandinavia

T2 - a systematic review

AU - Marks, Kevin P

AU - Madsen Sjö, Nina

AU - Wilson, Philip

N1 - © 2018 Mac Keith Press.

PY - 2019

Y1 - 2019

N2 - AIM: The aim of this systematic review was to investigate screening practices with the Ages and Stages Questionnaires (ASQ) and the Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) in the USA and Scandinavia and to identify practical lessons and research opportunities.METHOD: The review was performed for ASQ- and ASQ:SE-related studies in children from birth to 5 years. From nine databases and 1689 references (published from 1988-2018), 127 articles were included and categorized using Covidence online software. The Critical Appraisal Skills Programme Checklists were used before data synthesis.RESULTS: US studies primarily use the ASQ/ASQ:SE to detect delays in general and at-risk populations in medical settings, which increases early detection, clinician-referral, and intervention rates. Scandinavian studies commonly use the ASQ/ASQ:SE to monitor developmental-behavioural differences in intervention/exposure-based cohorts. Pre-visit screening yields completion/return rates of 83% to more than 90% and fosters same-day interpretation. When referrals are indicated, systemwide care coordination or colocation with a developmental-behavioural specialist is beneficial.INTERPRETATION: Practical implementation lessons are reviewed. Research opportunities include investigating and measuring the ASQ/ASQ:SE's 'overall' sections. Danish, Norwegian, and Swedish translations are available but up-to-date norming and validation studies are needed throughout Scandinavia. Randomized controlled trials are needed to investigate outcomes in screened versus unscreened cohorts.WHAT THIS PAPER ADDS: General and at-risk populations broadly benefited from periodic Ages and Stages Questionnaires (ASQ) and/or Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) screening. Pre-visit ASQ and/or ASQ:SE screenining implementation systems work best. The ASQ and ASQ:SE 'overall' sections are not quantifiable and under-researched.

AB - AIM: The aim of this systematic review was to investigate screening practices with the Ages and Stages Questionnaires (ASQ) and the Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) in the USA and Scandinavia and to identify practical lessons and research opportunities.METHOD: The review was performed for ASQ- and ASQ:SE-related studies in children from birth to 5 years. From nine databases and 1689 references (published from 1988-2018), 127 articles were included and categorized using Covidence online software. The Critical Appraisal Skills Programme Checklists were used before data synthesis.RESULTS: US studies primarily use the ASQ/ASQ:SE to detect delays in general and at-risk populations in medical settings, which increases early detection, clinician-referral, and intervention rates. Scandinavian studies commonly use the ASQ/ASQ:SE to monitor developmental-behavioural differences in intervention/exposure-based cohorts. Pre-visit screening yields completion/return rates of 83% to more than 90% and fosters same-day interpretation. When referrals are indicated, systemwide care coordination or colocation with a developmental-behavioural specialist is beneficial.INTERPRETATION: Practical implementation lessons are reviewed. Research opportunities include investigating and measuring the ASQ/ASQ:SE's 'overall' sections. Danish, Norwegian, and Swedish translations are available but up-to-date norming and validation studies are needed throughout Scandinavia. Randomized controlled trials are needed to investigate outcomes in screened versus unscreened cohorts.WHAT THIS PAPER ADDS: General and at-risk populations broadly benefited from periodic Ages and Stages Questionnaires (ASQ) and/or Ages and Stages Questionnaires: Social-Emotional (ASQ:SE) screening. Pre-visit ASQ and/or ASQ:SE screenining implementation systems work best. The ASQ and ASQ:SE 'overall' sections are not quantifiable and under-researched.

U2 - 10.1111/dmcn.14044

DO - 10.1111/dmcn.14044

M3 - Review

VL - 61

SP - 419

EP - 430

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 4

ER -

ID: 217944127